Vida Ventures II, LLC
CIK: 0001776851
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Aktis Oncology, Inc.
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Jan 12, 2026AKTS
Aktis Oncology, Inc.
Conversion(C)Indirect4.9M shares- - Jan 12, 2026AKTS
Aktis Oncology, Inc.
Purchase(P)Indirect812.5K shares at avg. $18.00$14.6M - Jan 12, 2026AKTS
Aktis Oncology, Inc.
Conversion(C)Indirect134.8K shares- - Jan 12, 2026AKTS
Aktis Oncology, Inc.
Purchase(P)Indirect22.5K shares at avg. $18.00$406K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jan 12, 2026 | AKTS Aktis Oncology, Inc. | Conversion(C) | 4,859,370 | - | $0 | Indirect |
| Jan 12, 2026 | AKTS Aktis Oncology, Inc. | Purchase(P) | 812,455 | $18.00 | $14,624,190 | Indirect |
| Jan 12, 2026 | AKTS Aktis Oncology, Inc. | Conversion(C) | 134,842 | - | $0 | Indirect |
| Jan 12, 2026 | AKTS Aktis Oncology, Inc. | Purchase(P) | 22,545 | $18.00 | $405,810 | Indirect |
1-4 of 4 transactions
About Vida Ventures II, LLC
Vida Ventures II, LLC (SEC CIK 0001776851) files insider reports with the SEC as 10% Owner of Aktis Oncology, Inc. (AKTS).
Signal8 holds 2 ownership filings by Vida Ventures II, LLC (1 Form 3, 1 Form 4), filed between Jan 8, 2026 and Jan 12, 2026. Those filings report 4 transactions, the latest on Jan 12, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Vida Ventures II, LLC's filings is in LOS ANGELES, CA.
Recent filings by Vida Ventures II, LLC
Other insiders filing for Aktis Oncology, Inc. (AKTS)
- Czibere Akos, Chief Medical Officer
- Herrmann Ken, Director
- Ron-Bigger Shulamit, Chief Operating Officer
- Gormley Glenn, Director
- ELI LILLY & Co, 10% Owner
- Foley Todd, Director